Cambridge University Hospitals NHS Foundation Trust

Cambridge University Hospitals NHS Foundation Trust is a major academic NHS provider in the East of England. It operates two principal hospitals, Addenbrooke's Hospital and the Rosie Hospital, and is a world-renowned centre for biomedical research and education. The trust forms a key part of the Cambridge Biomedical Campus, one of Europe's largest and most significant life-science clusters.

History

The origins of the trust are deeply rooted in the history of Addenbrooke's Hospital, which was founded in 1766 on Trumpington Street following a bequest from John Addenbrooke, a fellow of Catharine Hall. The hospital moved to its current site on Hills Road in the 1970s. The trust itself was established in 1993, initially as Cambridge University Hospitals NHS Trust, and later achieved foundation trust status in 2004. A pivotal development was the opening of the Rosie Hospital for maternity services in 1983, named after its predecessor. The trust's evolution has been closely tied to the expansion of the Cambridge Biomedical Campus, which now hosts major partners like the MRC Laboratory of Molecular Biology and the Wellcome Sanger Institute.

Hospitals and services

The trust's primary clinical sites are Addenbrooke's Hospital, a major acute and specialist centre, and the Rosie Hospital, a dedicated maternity facility. It provides a comprehensive range of regional and supra-regional services, including specialist care in areas such as transplant surgery, neurosurgery, and oncology. The trust is a designated major trauma centre for the East of England Ambulance Service region and hosts the East of England Organ Retrieval Service. Key departments include the Cambridge Cancer Centre, the Cambridge Heart Centre, and the Cambridge Liver Unit. Clinical services are integrated with research facilities on the Cambridge Biomedical Campus, including the Royal Papworth Hospital and the Cambridge Institute for Medical Research.

Teaching and research

As a principal teaching hospital for the University of Cambridge School of Clinical Medicine, the trust is integral to the education of medical students and the training of junior doctors through its association with Health Education England. It is a global leader in biomedical research, with its work underpinned by partnerships with the University of Cambridge, the Medical Research Council, and the Wellcome Trust. The trust hosts the NIHR Cambridge Biomedical Research Centre and the Cambridge Clinical Trials Unit. Pioneering research conducted here has contributed to advances in genomics, stem cell therapy, and immunology, with notable contributions to projects like the Human Genome Project and the COVID-19 Genomics UK Consortium.

Performance and rankings

The trust is consistently highly rated in national assessments, having been awarded an 'Outstanding' rating by the Care Quality Commission. It frequently ranks among the top hospitals in the United Kingdom in surveys such as those conducted by the Dr Foster Hospital Guide. The trust's clinical outcomes, particularly in specialist areas like cancer care and transplantation, are benchmarked against national standards set by NHS England and are often cited as exemplary. Its research output and innovation are recognized in global rankings, including the Nature Index, which tracks high-quality scientific publication.

Governance and finances

The trust is governed by a Board of directors and a Council of Governors elected from its membership, which includes public, patient, and staff constituencies. It is regulated by NHS Improvement and must submit annual plans to Monitor. As a foundation trust, it has greater financial and operational autonomy than standard NHS trusts. Its finances are complex, with income derived from NHS England contracts, NICE-approved specialist service tariffs, and significant grants from bodies like the National Institute for Health Research and the European Research Council for its research portfolio.